Novartis says 30 pipeline drugs with ‘significant potential’ will drive long-term growth.
Swiss pharmaceutical giant Novartis lifted its mid-term guidance ahead of an investor conference on Thursday as it raised confidence in ...
Read more
Why Takeda no longer has an ‘IT department’ as part of drugmaker’s digital and data transformation
When Gabriele Ricci became chief data and technology officer at Takeda Pharmaceuticals, one of the biggest cultural changes he made ...
Read more
